История изучения ювенильной фибромиалгии: к 40-летию первого описания. Часть III. Лечение и прогноз
ОБЗОРЫ
Аннотация
M.B. Yunus и A.T. Masi в феврале 1985 года впервые описали 33 случая ювенильной первичной фибромиалгии (ЮФМ) и предложили ее диагностические критерии, однако и 40 лет спустя практикующие врачи зачастую испытывают затруднения при ее диагностике и лечении. Это во многом связано с недостаточной информированностью детских врачей о данной проблеме, так как в доступной зарубежной литературе информации о ЮФМ на несколько порядков меньше, чем о фибромиалгии у взрослых пациентов, а в русскоязычных научных статьях вопросы ЮФМ практически не обсуждаются. Большинство опубликованных ранее обзоров литературы, посвященной ЮФМ, как правило, приводят информацию не только непосредственно о ней, но и в большей степени о фибромиалгии у взрослых, что не вполне корректно, так как существует целый ряд уникальных особенностей ЮФМ и ее отличий от фибромиалгии у взрослых. Цель настоящего обзора — обобщить оригинальные исследования ЮФМ, избегая ссылок на исследования с участием только взрослых пациентов. В части III статьи приведены данные о лечении и прогнозе ЮФМ.
Библиографические ссылки
1. Romano T.J. Fibromyalgia in children; diagnosis and treatment. W V Med J. 1991;87(3):112–4.
2. Saccomani L., Vigliarolo M.A., Sbolgi P. et al. Sindrome fibromialgica giovanile: due casi clinici [Juvenile fibromyalgia syndrome: 2 clinical cases]. Pediatr Med Chir. 1993;15(1):99–101. (In Italian).
3. Bassan H., Niv D., Jourgenson U. et al. Localized fibromyalgia in a child. Paediatr Anaesth. 1995;5(4):263–5. https://doi.org/10.1111/j.1460-9592.1995.tb00296.x.
4. Kashikar-Zuck S., Parkins I.S., Graham T.B. et al. Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin J Pain. 2008;24(7):620–6. https://doi.org/10.1097/AJP.0b013e31816d7d23.
5. Mariutto E.N., Stanford S.B., Kashikar-Zuck S. et al. An exploratory, open trial of fluoxetine treatment of juvenile fibromyalgia. J Clin Psychopharmacol. 2012;32(2):293–5. https://doi.org/10.1097/JCP.0b013e31824858dc.
6. Arnold L.M., Bateman L., Palmer R.H., Lin Y. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. Pediatr Rheumatol Online J. 2015;13:27. https://doi.org/10.1186/s12969-015-0025-9.
7. Arnold L.M., Schikler K.N., Bateman L. et al. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatr Rheumatol Online J. 2016;14(1):46. https://doi.org/10.1186/s12969-016-0106-4.
8. Upadhyaya H.P., Arnold L.M., Alaka K., et al. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial. Pediatr Rheumatol Online J. 2019;17(1):27. https://doi.org/10.1186/s12969-019-0325-6.
9. Hengartner M.P., Plöderl M. Suicidality and other severe psychiatric events with duloxetine: Re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia. Int J Risk Saf Med. 2021;32(3):209–218. https://doi.org/10.3233/JRS-200033.
10. Habib S., Alatassi E.U., Mahmoud A. et al. Cognitive Behavioral Therapy Treating Juvenile Fibromyalgia. Cureus. 2021;13(1):e12496. https://doi.org/10.7759/cureus.12496.
11. Alkhawashki S.H., Algarzae N. Depression with comorbid juvenile-onset fibromyalgia syndrome novel treatment plan using interpersonal psychotherapy: A case report. Medicine (Baltimore). 2024;103(36):e39505.
12. Сантимов А.В., Гречаный С.В., Новик Г.А. Нарушения психического здоровья у детей с ревматическими заболеваниями. Научно-практическая ревматология. 2024;62(1):109–117. https://doi.org/10.47360/1995-4484-2024-109-117.
13. Tsao J.C., Meldrum M., Kim S.C. et al. Treatment Preferences for CAM in children with chronic pain. Evid Based Complement Alternat Med. 2007;4(3):367–74. https://doi.org/10.1093/ecam/nel084.
14. Verkamp E.K., Flowers S.R., Lynch-Jordan A.M. et al. A survey of conventional and complementary therapies used by youth with juvenile-onset fibromyalgia. Pain Manag Nurs. 2013;14(4):e244–e250. https://doi.org/10.1016/j.pmn.2012.02.002.
15. Miyamae T., Seki M., Naga T. et al. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep. 2013;18(1):12–9. https://doi.org/10.1179/1351000212Y.0000000036.
16. Ali A., Weiss T.R., Dutton A. et al. Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes: A Pilot Cohort Study. J Pediatr. 2017;183:184–190. https://doi.org/10.1016/j.jpeds.2016.12.053.
17. Walco G.A., Ilowite N.T. Cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome. J Rheumatol. 1992;19(10):1617–9.
18. Kashikar-Zuck S., Swain N.F., Jones B.A., Graham T.B. Efficacy of cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome. J Rheumatol. 2005;32(8):1594–602.
19. Degotardi P.J., Klass E.S., Rosenberg B.S. et al. Development and evaluation of a cognitive-behavioral intervention for juvenile fibromyalgia. J Pediatr Psychol. 2006;31(7):714–23. https://doi.org/10.1093/jpepsy/jsj064.
20. Lommel K., Bandyopadhyay A., Martin C. et al. A pilot study of a combined intervention for management of juvenile primary fibromyalgia symptoms in adolescents in an inpatient psychiatric unit. Int J Adolesc Med Health. 2011;23(3):193–7. https://doi.org/10.1515/ijamh.2011.043.
21. Kashikar-Zuck S., Ting T.V., Arnold L.M. et al. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum. 2012;64(1):297–305. https://doi.org/10.1002/art.30644.
22. Joffe N.E., Lynch-Jordan A., Ting T.V. et al. Utility of the Peds QL rheumatology module as an outcome measure in juvenile fibromyalgia. Arthritis Care Res (Hoboken). 2013;65(11):1820–7. https://doi.org/10.1002/acr.22045.
23. Sil S., Arnold L.M., Lynch-Jordan A. et al. Identifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia. Pain. 2014;155(7):1206–1212. https://doi.org/10.1016/j.pain.2014.03.005.
24. Kashikar-Zuck S., Sil S., Lynch-Jordan A.M. et al. Changes in pain coping, catastrophizing, and coping efficacy after cognitive-behavioral therapy in children and adolescents with juvenile fibromyalgia. J Pain. 2013;14(5):492–501. https://doi.org/10.1016/j.jpain.2012.12.019.
25. Kashikar-Zuck S., Flowers S.R., Strotman D. et al. Physical activity monitoring in adolescents with juvenile fibromyalgia: findings from a clinical trial of cognitive-behavioral therapy. Arthritis Care Res (Hoboken). 2013;65(3):398–405. https://doi.org/10.1002/acr.21849.
26. Stephens S., Feldman B.M., Bradley N. et al. Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: results of a randomized controlled pilot trial. Arthritis Rheum. 2008;59(10):1399–406. https://doi.org/10.1002/art.24115.
27. Kashikar-Zuck S., Flowers S.R., Verkamp E. et al. Actigraphy-based physical activity monitoring in adolescents with juvenile primary fibromyalgia syndrome. J Pain. 2010;11(9):885–93. https://doi.org/10.1016/j.jpain.2009.12.009.
28. Olsen M.N., Sherry D.D., Boyne K. et al. Relationship between sleep and pain in adolescents with juvenile primary fibromyalgia syndrome. Sleep. 2013;36(4):509–16. https://doi.org/10.5665/sleep.2534.
29. Sherry D.D., Brake L., Tress J.L. et al. The Treatment of Juvenile Fibromyalgia with an Intensive Physical and Psychosocial Program. J Pediatr. 2015;167(3):731–7. https://doi.org/10.1016/j.jpeds.2015.06.036.
30. Kashikar-Zuck S., Tran S.T., Barnett K. et al. A Qualitative Examination of a New Combined Cognitive-Behavioral and Neuromuscular Training Intervention for Juvenile Fibromyalgia. Clin J Pain. 2016;32(1):70–81. https://doi.org/10.1097/AJP.0000000000000221.
31. Tran S.T., Thomas S., Di Cesare C. et al. A pilot study of biomechanical assessment before and after an integrative training program for adolescents with juvenile fibromyalgia. Pediatr Rheumatol Online J. 2016;14(1):43. https://doi.org/10.1186/s12969-016-0103-7.
32. Tran S.T., Guite J.W., Pantaleao A. et al. Preliminary Outcomes of a Cross-Site Cognitive-Behavioral and Neuromuscular Integrative Training Intervention for Juvenile Fibromyalgia. Arthritis Care Res (Hoboken). 2017;69(3):413–420. https://doi.org/10.1002/acr.22946.
33. Kashikar-Zuck S., Black W.R., Pfeiffer M. et al. Pilot Randomized Trial of Integrated Cognitive-Behavioral Therapy and Neuromuscular Training for Juvenile Fibromyalgia: The FIT Teens Program. J Pain. 2018;19(9):1049–1062. https://doi.org/10.1016/j.jpain.2018.04.003.
34. Fussner L.M., Black W.R., Lynch-Jordan A. et al. Utility of the PROMIS Pediatric Pain Interference Scale in Juvenile Fibromyalgia. J Pediatr Psychol. 2019;44(4):436–441. https://doi.org/10.1093/jpepsy/jsy110.
35. Black W.R., Di Cesare C.A., Thomas S. et al. Preliminary Evidence for the Fibromyalgia Integrative Training Program (FIT Teens) Improving Strength and Movement Biomechanics in Juvenile Fibromyalgia: Secondary Analysis and Results from a Pilot Randomized Clinical Trial. Clin J Pain. 2021;37(1):51–60. https://doi.org/10.1097/AJP.0000000000000888.
36. de la Vega R., Roset R., Galán S., Miró J. Fibroline: A mobile app for improving the quality of life of young people with fibromyalgia. J Health Psychol. 2018;23(1):67–78. https://doi.org/10.1177/1359105316650509.
37. Yunus M.B., Masi A.T. Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. Arthritis Rheum. 1985;28(2):138–45. https://doi.org/10.1002/art.1780280205.
38. Buskila D., Neumann L., Hershman E. et al. Fibromyalgia syndrome in children — an outcome study. J Rheumatol. 1995;22(3):525–8.
39. Siegel D.M., Janeway D., Baum J. Fibromyalgia syndrome in children and adolescents: clinical features at presentation and status at follow-up. Pediatrics. 1998;101(3 Pt 1):377–82. https://doi.org/10.1542/peds.101.3.377.
40. Mikkelsson M. One year outcome of preadolescents with fibromyalgia. J Rheumatol. 1999;26(3):674–82.
41. Gedalia A., García C.O., Molina J.F. et al. Fibromyalgia syndrome: experience in a pediatric rheumatology clinic. Clin Exp Rheumatol. 2000;18(3):415–9.
42. Eraso R.M., Bradford N.J., Fontenot C.N. et al. Fibromyalgia syndrome in young children: onset at age 10 years and younger. Clin Exp Rheumatol. 2007;25(4):639–44.
43. Kashikar-Zuck S., Parkins I.S., Ting T.V. et al. Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome. Rheumatology (Oxford). 2010;49(11):2204–9. https://doi.org/10.1093/rheumatology/keq254.
44. Kashikar-Zuck S., Cunningham N., Sil S. et al. Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood. Pediatrics. 2014;133(3):e592–600. https://doi.org/10.1542/peds.2013-2220.
45. Lynch-Jordan A.M., Sil S., Bromberg M. et al. Cross-Sectional Study of Young Adults Diagnosed With Juvenile Fibromyalgia: Social Support and Its Impact on Functioning and Mood. J Adolesc Health. 2015;57(5):482–7. https://doi.org/10.1016/j.jadohealth.2015.07.015.
46. Cunningham N.R., Tran S.T., Lynch-Jordan A.M. et al. Psychiatric Disorders in Young Adults Diagnosed with Juvenile Fibromyalgia in Adolescence. J Rheumatol. 2015;42(12):2427–33. https://doi.org/10.3899/jrheum.141369.
47. Kashikar-Zuck S., Cunningham N., Peugh J. et al. Long-term outcomes of adolescents with juvenile-onset fibromyalgia into adulthood and impact of depressive symptoms on functioning over time. Pain. 2019;160(2):433–441. https://doi.org/10.1097/j.pain.0000000000001415.
48. Weiss J.E., Schikler K.N., Boneparth A.D. et al. Demographic, clinical, and treatment characteristics of the juvenile primary fibromyalgia syndrome cohort enrolled in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Pediatr Rheumatol Online J. 2019;17(1):51. https://doi.org/10.1186/s12969-019-0356-z.
49. Daffin M., Lynch-Milder M.K., Gibler R.C. et al. A qualitative study of risk and resilience in young adult women with a history of juvenile-onset fibromyalgia. Pediatr Rheumatol Online J. 2021;19(1):128. https://doi.org/10.1186/s12969-021-00628-9.
